These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11741488)

  • 1. 2-(2-Piperidyl)- and 2-(2-pyrrolidyl)chromans as nicotine agonists: synthesis and preliminary pharmacological characterization.
    Efange SM; Tu Z; von Hohenberg K; Francesconi L; Howell RC; Rampersad MV; Todaro LJ; Papke RL; Kung MP
    J Med Chem; 2001 Dec; 44(26):4704-15. PubMed ID: 11741488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UB-165: a novel nicotinic agonist with subtype selectivity implicates the alpha4beta2* subtype in the modulation of dopamine release from rat striatal synaptosomes.
    Sharples CG; Kaiser S; Soliakov L; Marks MJ; Collins AC; Washburn M; Wright E; Spencer JA; Gallagher T; Whiteaker P; Wonnacott S
    J Neurosci; 2000 Apr; 20(8):2783-91. PubMed ID: 10751429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of dopamine release by nicotinic acetylcholine receptor ligands in rat brain slices correlates with the profile of high, but not low, sensitivity alpha4beta2 subunit combination.
    Anderson DJ; Malysz J; Grønlien JH; El Kouhen R; Håkerud M; Wetterstrand C; Briggs CA; Gopalakrishnan M
    Biochem Pharmacol; 2009 Oct; 78(7):844-51. PubMed ID: 19555668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo neuronal nicotinic receptor properties of (+)- and (-)-pyrido[3,4]homotropane [(+)- and (-)-PHT]: (+)-PHT is a potent and selective full agonist at α6β2 containing neuronal nicotinic acetylcholine receptors.
    Carroll FI; Navarro HA; Mascarella SW; Castro AH; Luetje CW; Wageman CR; Marks MJ; Jackson A; Damaj MI
    ACS Chem Neurosci; 2015 Jun; 6(6):920-6. PubMed ID: 25891987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unichiral 2-(2'-pyrrolidinyl)-1,4-benzodioxanes: the 2R,2'S diastereomer of the N-methyl-7-hydroxy analogue is a potent α4β2- and α6β2-nicotinic acetylcholine receptor partial agonist.
    Bolchi C; Gotti C; Binda M; Fumagalli L; Pucci L; Pistillo F; Vistoli G; Valoti E; Pallavicini M
    J Med Chem; 2011 Nov; 54(21):7588-601. PubMed ID: 21942635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of AN317, a novel selective agonist of α6β2-containing nicotinic acetylcholine receptors.
    Sandager-Nielsen K; Ahring PK; Klein J; van Hout M; Thaneshwaran S; Dos Santos AB; Jacobsen TA; Amrutkar DV; Peters D; Jensen AA; Kohlmeier KA; Christophersen P; Dyhring T
    Biochem Pharmacol; 2020 Apr; 174():113786. PubMed ID: 31887288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterization of SIB-1765F: a novel cholinergic ion channel agonist.
    Sacaan AI; Reid RT; Santori EM; Adams P; Correa LD; Mahaffy LS; Bleicher L; Cosford ND; Stauderman KA; McDonald IA; Rao TS; Lloyd GK
    J Pharmacol Exp Ther; 1997 Jan; 280(1):373-83. PubMed ID: 8996218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SSR591813, a novel selective and partial alpha4beta2 nicotinic receptor agonist with potential as an aid to smoking cessation.
    Cohen C; Bergis OE; Galli F; Lochead AW; Jegham S; Biton B; Leonardon J; Avenet P; Sgard F; Besnard F; Graham D; Coste A; Oblin A; Curet O; Voltz C; Gardes A; Caille D; Perrault G; George P; Soubrie P; Scatton B
    J Pharmacol Exp Ther; 2003 Jul; 306(1):407-20. PubMed ID: 12682217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal nicotinic receptor beta2 and beta4 subunits confer large differences in agonist binding affinity.
    Parker MJ; Beck A; Luetje CW
    Mol Pharmacol; 1998 Dec; 54(6):1132-9. PubMed ID: 9855644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release.
    Clarke PB; Reuben M
    Br J Pharmacol; 1996 Feb; 117(4):595-606. PubMed ID: 8646402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical antipsychotics as noncompetitive inhibitors of alpha4beta2 and alpha7 neuronal nicotinic receptors.
    Grinevich VP; Papke RL; Lippiello PM; Bencherif M
    Neuropharmacology; 2009 Aug; 57(2):183-91. PubMed ID: 19481556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presynaptic alpha7 and non-alpha7 nicotinic acetylcholine receptors modulate [3H]d-aspartate release from rat frontal cortex in vitro.
    Rousseau SJ; Jones IW; Pullar IA; Wonnacott S
    Neuropharmacology; 2005 Jul; 49(1):59-72. PubMed ID: 15992581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selectivity of ABT-089 for alpha4beta2* and alpha6beta2* nicotinic acetylcholine receptors in brain.
    Marks MJ; Wageman CR; Grady SR; Gopalakrishnan M; Briggs CA
    Biochem Pharmacol; 2009 Oct; 78(7):795-802. PubMed ID: 19481067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct evidence that release-stimulating alpha7* nicotinic cholinergic receptors are localized on human and rat brain glutamatergic axon terminals.
    Marchi M; Risso F; Viola C; Cavazzani P; Raiteri M
    J Neurochem; 2002 Mar; 80(6):1071-8. PubMed ID: 11953457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New quinoline derivatives as nicotinic receptor modulators.
    Manetti D; Bellucci C; Dei S; Teodori E; Varani K; Spirova E; Kudryavtsev D; Shelukhina I; Tsetlin V; Romanelli MN
    Eur J Med Chem; 2016 Mar; 110():246-58. PubMed ID: 26840365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinic agonists stimulate acetylcholine release from mouse interpeduncular nucleus: a function mediated by a different nAChR than dopamine release from striatum.
    Grady SR; Meinerz NM; Cao J; Reynolds AM; Picciotto MR; Changeux JP; McIntosh JM; Marks MJ; Collins AC
    J Neurochem; 2001 Jan; 76(1):258-68. PubMed ID: 11145999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C3-halogenation of cytisine generates potent and efficacious nicotinic receptor agonists.
    Abin-Carriquiry JA; Voutilainen MH; Barik J; Cassels BK; Iturriaga-Vásquez P; Bermudez I; Durand C; Dajas F; Wonnacott S
    Eur J Pharmacol; 2006 Apr; 536(1-2):1-11. PubMed ID: 16563372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of N-substituted 4-(4-hydroxyphenyl)piperidines, 4-(4-hydroxybenzyl)piperidines, and (+/-)-3-(4-hydroxyphenyl)pyrrolidines: selective antagonists at the 1A/2B NMDA receptor subtype.
    Guzikowski AP; Tamiz AP; Acosta-Burruel M; Hong-Bae S; Cai SX; Hawkinson JE; Keana JF; Kesten SR; Shipp CT; Tran M; Whittemore ER; Woodward RM; Wright JL; Zhou ZL
    J Med Chem; 2000 Mar; 43(5):984-94. PubMed ID: 10715162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different nicotinic acetylcholine receptor subtypes mediating striatal and prefrontal cortical [3H]dopamine release.
    Cao YJ; Surowy CS; Puttfarcken PS
    Neuropharmacology; 2005 Jan; 48(1):72-9. PubMed ID: 15617729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107.
    Malysz J; Anderson DJ; Grønlien JH; Ji J; Bunnelle WH; Håkerud M; Thorin-Hagene K; Ween H; Helfrich R; Hu M; Gubbins E; Gopalakrishnan S; Puttfarcken PS; Briggs CA; Li J; Meyer MD; Dyhring T; Ahring PK; Nielsen EØ; Peters D; Timmermann DB; Gopalakrishnan M
    J Pharmacol Exp Ther; 2010 Sep; 334(3):863-74. PubMed ID: 20504915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.